Gary Penny
Psychiatry · San Antonio, TXNPI 1184738643
Payments from drug & device makers
Across 300 payments — averaging $20.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Otsuka America Pharmaceutical, Inc.$778
- Avanir Pharmaceuticals, Inc.$627
- Eisai Inc.$524
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$363
- Ironshore Pharmaceuticals Inc.$343
- plus $2K from 18 others
What the payments were for
- Food & beverage$6,13899%
- Education$331%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 107 | $1,352 |
| Otsuka America Pharmaceutical, Inc. | 32 | $778 |
| Avanir Pharmaceuticals, Inc. | 33 | $627 |
| Eisai Inc. | 10 | $524 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 17 | $363 |
| Ironshore Pharmaceuticals Inc. | 22 | $343 |
| Teva Pharmaceuticals USA, Inc. | 7 | $339 |
| Lundbeck LLC | 16 | $314 |
| Vanda Pharmaceuticals Inc. | 7 | $235 |
| Johnson & Johnson | 6 | $222 |
| Bausch Health US, LLC | 10 | $181 |
| Idorsia Pharmaceuticals US Inc | 5 | $167 |
| Supernus Pharmaceuticals, Inc. | 7 | $131 |
| E.r. Squibb & Sons, L.L.C. | 1 | $125 |
| Axsome Therapeutics, Inc. | 5 | $112 |
| Alkermes, Inc. | 1 | $86 |
| Sunovion Pharmaceuticals Inc. | 4 | $54 |
| Arbor Pharmaceuticals, Inc. | 2 | $51 |
| Merck | 2 | $42 |
| Jazz Pharmaceuticals Inc. | 2 | $35 |
| Brainsway USA Inc | 1 | $28 |
| Livanova USA, Inc. | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Shire North American Group Inc | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,170 in reported general payments places this provider in the 85th percentile of 2,238 psychiatry providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| NuplazidPimavanserin Tartrate | 11 | $54,945 |
| EmsamSelegiline | 11 | $36,603 |
| ClozarilClozapine | 12 | $28,824 |
| NeuproRotigotine | 25 | $26,830 |
| VraylarCariprazine Hcl | 14 | $19,306 |
| Clozapine OdtClozapine | 13 | $14,017 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 170 | $12,386 |
| FetzimaLevomilnacipran Hcl | 12 | $7,259 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 89 | $3,454 |
| Quetiapine Fumarate | 130 | $2,831 |
| Lamotrigine | 207 | $2,761 |
| KlonopinClonazepam | 11 | $2,431 |
| Clonazepam | 256 | $2,377 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 59 | $2,355 |
| Selegiline Hcl | 17 | $2,108 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar, Fetzima | $1,352 | $26,56526 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,238 psychiatry providers in Texas.
Other psychiatry in San Antonio
- Thomas WeissSan Antonio$1.1M
- Jason MillerSan Antonio$869K
- Nathan JohnstonSan Antonio$435K
- Scott BartleyDallas$42.7M
- David BrownAustin$15.8M
- Rajinder ShiwachDesoto$15.4M
- Darin OkudaDallas$14.7M
- Jason MensahBeaumont$10.3M
- Michael DowningDallas$7.6M
- Rakesh JainLake Jackson$7.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.